Sodium cromoglicate oral - Emisphere
Alternative Names: Cromoglicic acid oral - Emisphere; Cromoglycic acid oral - Emisphere; Cromolyn oral - Emisphere; Cromolyn sodium oral - Emisphere; Oral cromoglicic acid; Oral cromoglycic acid; Oral cromolyn; Oral cromolyn sodium; Oral sodium cromoglicate; Sodium cromoglycate oral - EmisphereLatest Information Update: 15 Oct 2021
Price :
$50 *
At a glance
- Originator Emisphere Technologies
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antitussives; Benzopyrans; Chromones; Nootropics; Small molecules
- Mechanism of Action Mast cell stabilisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Hypersensitivity
Most Recent Events
- 08 Dec 2020 Emisphere Technologies has been acquired by Novo Nordisk
- 08 Aug 2005 Phase-I clinical trials in Allergy in USA (PO)
- 08 Aug 2005 Phase-I clinical trials in Asthma in USA (PO)